Stallergenes Greer is hosting a 'Perspectives in AIT: 2022 and Beyond' scientific symposium as a webinar on Thursday 17th March 2022 6.00 – 7.30 pm AEDST (5.00 - 6.30 pm Brisbane / 5.30 – 7.00 pm Adelaide / 3.00 – 4.30 pm Perth / 8.00 – 9.30 pm Auckland).  The program and presenters are listed below.

To register go to https://us02web.zoom.us/meeting/register/tZUkd-6spjwrHNyyWuMIJxbrUnx-O1sXbOFr

For more details please refer to the pdf: Allergen Immunotherapy 17 March 2022 Invitation162.73 KB

PLENARY (30 min): Evidence-based approaches to house dust mite ait: international insights and trends.

EXPERT PANEL (30 min): Burdens, risks and optimal management of springtime allergy: latest australian data

Featuring ‘snapshots’ of the very latest local research presented by:

Prof. Jo Douglass (Melbourne)
James Stewart Chair of Medicine, University of Melbourne; Director of Research, Royal Melbourne Hospital

Prof. Sheryl van Nunen OAM (Sydney)
Clinical Professor, Macquarie University; Clinical Associate Professor, Northern Clinical School, University of Sydney; Visiting Medical Officer, Northern Beaches Hospital

Prof. Simon Haberle (Canberra)
Professor of Natural History, Director of the School of Culture, History and Language, Australian National University; Pollen lead for AirRater, ACT

A/Prof. Ed Newbigin (Melbourne)
Botanist, School of BioSciences, University of Melbourne; Co-ordinator, Melbourne Pollen Count Team

COMBINED Q&A SESSION (30 min): Prof. Pfaar and the Australian Expert Panel will provide a platform to explore an overarching question: Based on the latest science, what approaches and future directions would inform the prescription of AIT to allergy sufferers in Australia?

Chair: A/Prof. Kymble Spriggs
Clinical Associate Professor, University of Melbourne

This news item was issued on 24 February 2022 by the Australasian Society of Clinical Immunology and Allergy (ASCIA), the peak professional body for clinical immunology and allergy in Australia and New Zealand.